Plasma cannabinoids measured by radioimmunoassay in rabbits after intravenous injection of tetrahydrocannibinol, 11-hydroxy-tetrahydrocannabinol, cannabinol and cannabidiol.
An antiserum raised in sheep against a conjugate of tetrahydrocannabinol with bovine serum albumin has been used as the basis of a radioimmunoassay for cannabinoids in the blood of rabbits given tetrahydrocannabinol, 11-hydroxy-tetrahydrocannabinol, cannabinol or cannabidiol by rapid intravenous injection. In the case of both 11-hydroxy-tetrahydrocannabinol and cannabinol plasma cannabinoid concentrations fell exponentially from an initial peak plasma level attained immediately after the completion of intravascular distribution of the injected bolus. In the case of tetrahydrocannabinol itself, however, there was a progressive rise in plasma cannabinoid concentration between five and fifteen minutes after the rapid intravenous injection. The reasons for this rise in plasma cannabinoid concentration are discussed.
D000818:Animals; D000918:Antibody Specificity; D002185:Cannabidiol / Q000378:metabolism*; D002188:Cannabis / Q000097:blood* / Q000378:metabolism*; D013759:Dronabinol / Q000031:analogs & derivatives / Q000378:metabolism*; D006207:Half-Life; D006900:Hydroxylation; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay; D013997:Time Factors
D002185:Cannabidiol; D013759:Dronabinol